imaging follow-up results

5 trials

Sponsors

The First Affiliated Hospital of Harbin Medical University, The First Affiliated Hospital Of Zhengzhou University, Affiliated Hospital of Qingdao University

Conditions

Benign and malignant tumorsVarious Diseases (e.g. cancer, inflammation, tuberculosis, etc.)lung cancermalignant solid tumorprostatic cancer

Early Phase 1

Application of 18F-PSMA-1007 PET/CT imaging in diagnosis and treatment of prostate cancer

RecruitingChiCTR2200059170

The First Affiliated Hospital Of Zhengzhou Universityprostatic cancer

Start: 2020-10-01Updated: 2024-02-19

18F-FAPI PET/CT Imaging in Patients With Various Diseases

RecruitingChiCTR2200061236

Affiliated Hospital of Qingdao UniversityVarious Diseases (e.g. cancer, inflammation, tuberculosis, etc.)

Start: 2022-06-03Updated: 2023-03-26

Unknown Phase

Comparison of new imaging agent Al[18F]-FAPI-04 with 18F-FDG in solid tumor imaging.

Active, not recruitingChiCTR2100051406

The First Affiliated Hospital of Harbin Medical Universitymalignant solid tumor

Start: 2021-05-01Updated: 2022-06-20

Novel tracer 99mTc-FAPI SPECT/CT fusion imaging in lung cancer

RecruitingChiCTR2300078405

The First Affiliated Hospital of Harbin Medical Universitylung cancer

Start: 2023-05-08Updated: 2023-12-10

Clinical application of Al18F-FAPI04 PET imaging in benign and malignant diseases

RecruitingChiCTR2500099500

The First Affiliated Hospital of Harbin Medical UniversityBenign and malignant tumors

Start: 2024-01-24Updated: 2025-03-31

Related Papers

<sup>18</sup>F-FAPI-04 PET/CT in the evaluation of ground-glass nodules less than 3 cm in diameter comparing to <sup>18</sup>F-FDG PET/CT.

2025-11-10

Clinical application of Al18F-NOTA-FAPI PET/CT in diagnosis and TNM staging of pancreatic adenocarcinoma, compared to 18F-FDG

Cancer Imaging2023-09-1214 citations